Visalytics
Visalytics
approved EB-2 (NIW)

Internal Medicine Resident

Internal Medicine · Nepal · 2025-06-04

Processing Time
23 days
Decision Date
2025-06-04
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her evidence-based observational and translational research to improve patient outcomes in ischemic stroke, infectious diseases, and preventive cardiovascular care. Her work focuses on identifying critical risk factors like hyperuricemia to inform early diagnosis and intervention strategies. Additionally, she intends to lead clinical studies on treatment adherence, antimicrobial resistance, and lifestyle interventions in her role as a primary care physician.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses major causes of disability and death in the U.S., such as ischemic strokes and cardiovascular disease.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record in the top 10% of her field and her clinical background demonstrate her capability to lead the proposed work.

3 Waiver Benefit Met

On balance, the petitioner's contributions to improving diagnostic accuracy and reducing healthcare burdens justify waiving the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal publications and 2 preprint platforms, which garnered over 25 citations. One specific study on hyperuricemia and stroke ranked in the top 10% of most-cited articles in Clinical Medicine for its year. The case was supported by expert testimony and demonstrated alignment with national health priorities, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-2 (NIW) approved
USA 141 days 2025-04-03
The petitioner proposes to investigate the molecular mechanisms underlying cardiovascular diseases to translate these insights into new pharmaceutical therapies. The work involves conducting research within U.S. academic environments to develop treatment paths that minimize invasive procedures and improve cardiovascular outcomes.
View Case

Doctor

Healthcare · Pakistan

WeGreened EB-2 (NIW) rfe approved
Pennsylvania 94 days 2025-09-26
The petitioner proposes to advance research in cardiovascular and chronic disease outcomes by characterizing disease patterns and identifying healthcare disparities. The work integrates clinical observation and population-based data analysis with artificial intelligence to improve the management of conditions like atrial fibrillation and heart failure.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Neurologist

Healthcare · Indonesia

WeGreened EB-2 (NIW) approved
Rhode Island 420 days 2025-08-28
The petitioner proposes to enhance the treatment and prevention of cerebrovascular diseases by identifying effective acute interventions and developing secondary prevention strategies. Her work focuses on establishing modifiable risk factors to predict patient outcomes and addressing rare, complex presentations of stroke to improve diagnostic precision. The endeavor aims to reduce the global and national burden of stroke through improved clinical care strategies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 23 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist